Cardiol Therapeutics Inc. Increase Decrease In Cash And Cash Equivalents
Cardiol Therapeutics Inc. (CRDL) reported Increase Decrease In Cash And Cash Equivalents of -CAD 8.34 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2026-03-31
| Period end | Increase Decrease In Cash And Cash Equivalents 12 month | Increase Decrease In Cash And Cash Equivalents 12 month as first filed |
|---|---|---|
| 2025-12-31 | -8.34M CAD 40-F · filed 2026-03-31 | |
| 2024-12-31 | -6.24M CAD 40-F · filed 2026-03-31 | |
| 2023-12-31 | -25.30M CAD 40-F · filed 2025-03-31 | |
| 2022-12-31 | -27.35M CAD 20-F · filed 2024-04-01 | |
| 2021-12-31 | 69.89M CAD 20-F · filed 2024-04-01 | 69.87M CAD 40-F/A · filed 2022-04-20 |
| 2020-12-31 | 7.13M CAD 20-F · filed 2023-03-29 | 7.07M CAD 40-F/A · filed 2022-04-20 |